Tirzepatide vs Semaglutide: Evidence from Head-to-Head Trials – Mounjaro Metabolic Summit

Dr. Sudhir Bhandari contributed to the academic programme at Mounjaro Metabolic Summit with a session focused on Tirzepatide vs Semaglutide: Evidence from Head-to-Head Trials.

Programme: Mounjaro Metabolic Summit
Academic Focus: Tirzepatide vs Semaglutide: Evidence from Head-to-Head Trials